Literature DB >> 1864482

Recovery by mouse embryos following teratogenic exposure to ketosis.

L Shum1, T W Sadler.   

Abstract

Previous studies have shown that the ketone body D,L,-beta-hydroxybutyrate was teratogenic to mouse embryos exposed in culture during the period of neurulation. Inhibition of closure of the cranial and caudal neuropores was the most frequently occurring defect and these abnormalities were thought to be the forerunner of anencephaly and spina bifida, respectively. However, additional studies demonstrated that embryos could recover morphologically from these effects if the ketone body was removed from the culture medium and if the recovery period was of sufficient duration. In an attempt to define further the phenomenon responsible for this recovery and to determine the extent of the recovery process, the present study examining the cross-sectional area, cell number, and mitotic index of cranial neuroepithelial cells was conducted in mouse embryos cultured from the early somite stage under one of the following conditions: 1) control medium for 60 h; 2) medium containing 32 mmol/l D,L,-beta-hydroxybutyrate for 24 h followed by culture in control medium for an additional 36 h (recovery group); 3) medium containing 32 mmol/l D,L,-beta-hydroxybutyrate for 60 h (continuously exposed group). The results indicate that although neural tube closure occurred in the recovery group, complete recovery was limited to the ventral regions of the forebrain and that the remainder of the prosencephalon as well as the rhombencephalon failed to undergo complete catch-up growth. Thus, cell numbers in these areas were approximately 70% of control values. Therefore, while the gross anatomical disturbances produced by the ketone body may be compensated for, histological alterations in the affected tissues remain. Ultimately, these data suggest that neurological deficits may be an outcome of ketone body exposure during the early stages of embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864482     DOI: 10.1007/bf00404998

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Cell degeneration and recovery of the fetal mammalian brain after a chemical insult.

Authors:  J Langman; E L Cardell
Journal:  Teratology       Date:  1977-08

2.  Is compensatory growth a complicating factor in mouse teratology?

Authors:  M H Snow; P P Tam
Journal:  Nature       Date:  1979-06-07       Impact factor: 49.962

3.  Regeneration and recovery in the fetal nervous system after radiation injury.

Authors:  C J D'Amato
Journal:  Exp Neurol       Date:  1982-06       Impact factor: 5.330

4.  Neuropsychological deficits in children of diabetic mothers. A report from the Collaborative Sdy of Cerebral Palsy.

Authors:  J A Churchill; H W Berendes; J Nemore
Journal:  Am J Obstet Gynecol       Date:  1969-09-15       Impact factor: 8.661

5.  Effects of maternal diabetes on early embryogenesis. Alterations in morphogenesis produced by the ketone body, B-hydroxybutyrate.

Authors:  W E Horton; T W Sadler
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

6.  Embryonic catch-up growth after exposure to the ketone body D,L,-beta-hydroxybutyrate in vitro.

Authors:  L Shum; T W Sadler
Journal:  Teratology       Date:  1988-10

7.  An in vivo/in vitro evaluation of teratogenic action.

Authors:  A R Beaudoin; D L Fisher
Journal:  Teratology       Date:  1981-02

8.  Effects of beta-hydroxybutyrate on rat embryos grown in culture.

Authors:  E A Sheehan; F Beck; C A Clarke; M Stanisstreet
Journal:  Experientia       Date:  1985-02-15

9.  Mitochondrial alterations in embryos exposed to B-hydroxybutyrate in whole embryo culture.

Authors:  W E Horton; T W Sadler
Journal:  Anat Rec       Date:  1985-09

10.  Prevention of spinal neural tube defects in the mouse embryo by growth retardation during neurulation.

Authors:  A J Copp; J A Crolla; F A Brook
Journal:  Development       Date:  1988-10       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.